Form 4: AbbVie Executive Roopal Thakkar Reports Stock Disposal

Roopal Thakkar, EVP, R&D and CSO of AbbVie Inc., reported the disposal of 4,678 shares of common stock on February 28, 2025.

Summary

• Roopal Thakkar, an executive at AbbVie Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on February 28, 2025.
• Thakkar disposed of 4,678 shares of AbbVie common stock at a price of $205.02 per share.
• Following the transaction, Thakkar directly owns 42,276 shares of AbbVie common stock.

Sentiment

Score: 5

Explanation: This is a routine disclosure of a stock transaction by an executive, and doesn't inherently indicate positive or negative sentiment. It's a factual report.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like Roopal Thakkar, trade their company's stock. These filings provide transparency into the transactions of individuals with access to non-public information.

Stakeholder Impact

• The disposal of shares by an executive could be perceived negatively by some shareholders, but it's a common occurrence and doesn't necessarily indicate a lack of confidence in the company.

Key Dates